After a slow period, funding deals have picked up. An autonomous driving startup led the week, surprising many who thought the industry was stagnant. Significant raises also occurred in AI, biotech, space tech, and cybersecurity, hinting at a potential summer surge.
Cruise Secures $850M for Autonomous Cars General Motors invested another $850 million into Cruise, a San Francisco-based autonomous driving startup. Cruise, which secured the largest venture round in the U.S. in 2021 with a valuation over $30 billion, faced challenges in early 2022 when SoftBank withheld $1.35 billion, prompting GM to buy out SoftBank’s stake. The company also paused its self-driving taxi program after an incident in San Francisco. Cruise is now restarting its programs in Phoenix, Dallas, and Houston as GM continues to invest heavily in the autonomous driving market.
AlphaSense Raises $650M for AI Market Intelligence AlphaSense, an AI-driven market intelligence platform, raised $650 million in a round co-led by Viking Global Investors and BDT & MSD Partners, increasing its valuation to $4 billion—up 75% from nine months ago. AlphaSense also acquired Tegus, an expert research startup, for $930 million. The New York-based company uses AI and natural language processing to help clients form corporate and investment strategies, raising $1.4 billion since its founding.
Santa Ana Bio Gets $125M for Autoimmune Disease Research Santa Ana Bio, focused on autoimmune and inflammatory diseases, raised $125 million in a Series B round led by GV. Founded in 2021 and based in Alameda, California, the company has raised $168 million to date.
Alzheon Raises $100M for Alzheimer’s Treatment Alzheon secured $100 million in a Series E led by Alerce Medical Technology Partners. The Massachusetts-based firm develops treatments for Alzheimer’s and other neurodegenerative disorders, raising $237 million since its inception in 2013.
Apex Secures $95M for Satellite Bus Production Los Angeles-based Apex, a spacecraft manufacturing company, raised $95 million in a Series B led by XYZ Venture Capital and CRV to increase its production of satellite buses. Founded in 2022, Apex has raised $122 million so far and aims to meet the growing demand, including from the U.S. Department of Defense.
Cyberhaven Raises $88M for Data Detection and Response Cyberhaven, a data detection and response platform based in San Jose, raised $88 million in a Series C led by Adams Street Partners and Khosla Ventures. The company saw 200% growth in new bookings over the past year. Founded in 2016, Cyberhaven has raised nearly $137 million.
InduPro Secures $85M for Cancer Therapeutics Seattle-based InduPro, developing cancer and autoimmune disease therapeutics, closed an $85 million Series A co-led by The Column Group and Vida Ventures. This is the first funding round for the company since its founding in 2022.
Enveda Biosciences Gets $50M for AI-Driven Medicine Enveda Biosciences, based in Boulder, Colorado, announced a $55 million round. The company, using AI to develop medicines from plants, counts Microsoft among its new investors. Founded in 2019, Enveda has raised $230 million to date.
Canary Technologies Raises $50M for Hotel Management San Francisco-based Canary Technologies, a hotel management platform, raised $50 million in a Series C led by Insight Partners. Founded in 2017, Canary has raised nearly $100 million.
Posh AI Secures $45M for Banking Industry Solutions Posh AI, a Boston-based conversational AI platform for the banking industry, raised $45 million in a round led by Curql. Founded in 2018, Posh AI has raised nearly $73 million.
Major Global Deals
In Europe, Paris-based Mistral AI raised a significant round, valuing the OpenAI and Anthropic competitor at $6 billion. Mistral AI secured $500 million in equity and $140 million in debt, according to the Financial Times.
Methodology
This report tracks the largest announced rounds in the Crunchbase database for U.S.-based companies from June 8 to June 14. While most rounds are represented in the database, some may have a reporting lag.
